HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Emilia Scalzulli Selected Research
Emilia Scalzulli Research Topics
Disease
32
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2024 - 12/2017
6
Primary Myelofibrosis (Myelosclerosis)
02/2024 - 08/2019
6
Neoplasms (Cancer)
02/2024 - 08/2019
3
Polycythemia Vera
01/2023 - 10/2020
3
Splenomegaly
01/2023 - 08/2019
3
Anemia
01/2021 - 01/2019
2
Myeloid Leukemia (Leukemia, Myelocytic)
01/2023 - 12/2020
2
Hypertension (High Blood Pressure)
01/2023 - 07/2020
2
Leukemia
06/2022 - 01/2021
2
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 08/2019
1
Inflammation (Inflammations)
02/2024
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2023
1
Carcinoma (Carcinomatosis)
01/2023
1
Hematologic Diseases (Blood Diseases)
01/2023
1
Infections
01/2023
1
Melanoma (Melanoma, Malignant)
01/2023
1
Skin Neoplasms (Skin Cancer)
01/2023
1
Thrombocytosis (Thrombocythemia)
01/2023
1
Merkel Cell Carcinoma
01/2023
1
Abdominal Pain (Pain, Abdominal)
01/2023
1
Myocardial Ischemia (Ischemic Heart Diseases)
01/2023
1
Stroke (Strokes)
01/2023
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2023
1
Disease Progression
11/2022
1
Residual Neoplasm
01/2022
1
Dyslipidemias (Dyslipidemia)
08/2021
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2021
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Hydrocephalus (Hydrocephaly)
01/2021
1
Atrial Fibrillation
12/2020
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2020
1
Multiple Myeloma
01/2018
Drug/Important Bio-Agent (IBA)
21
Tyrosine Kinase Inhibitors
IBA
02/2024 - 12/2017
8
ruxolitinib
IBA
02/2024 - 08/2019
7
Imatinib Mesylate (Gleevec)
FDA Link
09/2023 - 01/2019
6
nilotinib
FDA Link
11/2023 - 01/2019
6
ponatinib
IBA
11/2023 - 01/2019
3
asciminib
IBA
01/2023 - 08/2021
3
Dasatinib (BMS 354825)
FDA Link
01/2023 - 01/2019
2
LDL Lipoproteins (beta Lipoproteins)
IBA
08/2021 - 01/2020
2
Phosphotransferases (Kinase)
IBA
12/2020 - 08/2019
2
Anticoagulants
IBA
12/2020 - 12/2020
2
Azacitidine (5 Azacytidine)
FDA Link
10/2020 - 08/2019
2
Erythropoietin
FDA Link
09/2020 - 01/2019
1
Biomarkers (Surrogate Marker)
IBA
02/2024
1
avelumab
IBA
01/2023
1
Hemoglobins (Hemoglobin)
IBA
01/2023
1
Lamivudine (Epivir)
FDA Link
01/2023
1
Lenalidomide (CC 5013)
FDA Link
01/2022
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
08/2021
1
cemiplimab
IBA
08/2021
1
oxidized low density lipoprotein
IBA
08/2021
1
Interferons
IBA
01/2021
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2021
1
Fibrinogen (Factor I)
FDA Link
01/2021
1
Cytokines
IBA
10/2020
1
Decitabine
FDA Link
10/2020
1
Angiotensin Receptor Antagonists
IBA
07/2020
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
07/2020
1
Triglycerides (Triacylglycerol)
IBA
01/2020
1
LDL Cholesterol
IBA
01/2020
1
Hydroxyurea (Hydrea)
FDA Link
Generic
08/2019
1
bosutinib
IBA
01/2019
1
Proteasome Inhibitors
IBA
01/2018
Therapy/Procedure
6
Therapeutics
09/2023 - 01/2018
1
Immunotherapy
01/2023
1
Secondary Prevention
01/2019